SLN

MKT CAP:$308M

Silence Therapeutics PLC

Market Cap

$308M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$6.17+$0.02 (+0.33%)

Jun 5, 2026

52W High $7.9752W Low $4.30

Company Details

Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardio...

CEO

—

IPO Date

Sep 8, 2020

Website

www.silence-therapeutics.com

Key Metrics TTM (GBP)

Revenue

£838.3K

-96.8% YoY

Net Income

-£75M

EPS (Diluted)

Free Cash Flow

-£66M

Revenue / Share

£0.02

Gross Margin

66.9%

Operating Margin

-9267.5%

Net Margin

-8948.4%

FCF Margin

-7833.9%

P/S

P/E

Earnings Reports

Q1 2026

May 7, 2026

£421.3K+196.7%

FY 2025

Mar 5, 2026

£559.0K-98.7%

Q4 2025

Mar 5, 2026

£34.0K-99.9%

Q3 2025

Nov 6, 2025

£159.0K-86.1%

Q2 2025

Aug 7, 2025

£224.0K-62.5%

Revenue & Profitability (GBP)

Operating Cash Flow (GBP)

CapEx Spend (GBP)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (GBP)

OpEx Breakdown (GBP)

War Chest (GBP)

Shares Outstanding

Revenue Per Employee (GBP)

Revenue / Employee